greeksoup/ stock research
Stock research / United States / VRTX / Documents

Vertex Pharmaceuticals Inc. documents

Vertex Pharmaceuticals (VRTX) annual report: the 10-K filed 13 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 2 April 2026; latest 10-Q filed 3 November 2026 for the quarter ended 30 September 2026. Each links to the document on EDGAR, with 4 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
2 November 2026Results press release, exhibit 99 to the 8-K filed 2 November 2026The releaseEDGAR folder
3 August 2026Results press release, exhibit 99 to the 8-K filed 3 August 2026The releaseEDGAR folder
4 May 2026Results press release, exhibit 99 to the 8-K filed 4 May 2026The releaseEDGAR folder
12 February 2026Results press release, exhibit 99 to the 8-K filed 12 February 2026The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
13 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
3 November 202610-Q, period ended 30 September 2026The documentEDGAR folder
4 August 202610-Q, period ended 30 June 2026The documentEDGAR folder
5 May 202610-Q, period ended 31 March 2026The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
2 April 2026DEF 14A, period ended 13 May 2026The documentEDGAR folder

Annual report to shareholders

FiledDocumentOpenWhere
2 April 2026ARS, period ended 31 December 2025The documentEDGAR folder